Alkermes plc - Ordinary Shares — Quarterly Financial Statistics (NASDAQ:ALKS) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities 98.81 M150.2 M101.67 M170.07 M-165.74 M 256.2 M Cash from investing activities 9.1 M-29.21 M-6.74 M322.35 M-2.08 B -1.79 B Cash from financing activities 747 K405 K315 K10.91 M1.47 B 1.49 B Free cash flow 98.81 M150.2 M101.67 M170.07 M-165.74 M 256.2 M

News

Arcturus Therapeutics (ARCT) Stock Jumps 5.7%: Will It Continue to Soar?

Is HRMY Stock Worth Buying With Neutral Signals and Cheap Valuation?

HRMY Growth Trends Beyond Wakix Could Shape Its Next Growth Phase

Alkermes: "Buy" On Avadel Acquisition And Positive NT2 Data With Alixorexton (NASDAQ:ALKS)

ALKS' Sleep Disorder Drug Gets Orphan Drug Tags in the U.S. & Europe

Alkermes plc (ALKS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Why Is Revolution Medicines (RVMD) Up 9.3% Since Last Earnings Report?

Alkermes (ALKS) Up 21.1% Since Last Earnings Report: Can It Continue?

Alkermes Analysts Increase Their Forecasts Following Strong Q1 Results - Alkermes (NASDAQ:ALKS)

Alkermes' Q1 Earnings & Revenues Beat Estimates, Stock Rises

Alkermes: A Sleep Medicine Platform Hidden Inside A Mature CNS Company (ALKS)

Alkermes (ALKS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates